Free delivery over $100 Learn more

30 days return period Learn more
SKU: 0432ATC

KMS-11 Human Pleural Effusion Immune Cells

Tumor Cell Lines > Myeloma Cell Lines

Product Type: Human Myeloma Cell Lines

Species: Human

Cell Type: Immune Cells

Source Organ: Effusion

$1,249.00
Size

Care information

Display general product information or specific product information using metafields.

Delivery and Shipping

Add some general information about your delivery and shipping policies.

Cell Name: KMS-11

Human myeloma cell line. Myeloma, pleural effusion infiltration (IgGk). Small round-cell morphology, part is multinucleate cell.

  • Description
    Human Myeloma Cell Line KMS-11 is derived from pleural effusion of a 67-year-old Japanese female patient with multiple myeloma. These cells are B-cell type and exhibit small round morphology with some multinucleate forms. They secrete immunoglobulin κ (IgG κ) and show positive reaction with PCA-1. KMS-11 has chromosomal abnormalities. The cell line carries a FGFR3 gene mutation (p.Tyr373Cys) and expresses high levels of tumor markers. In terms of tumorigenicity, KMS-11 does not show tumor formation in subcutaneous nude mouse models. They display unique growth properties, including both adherent and suspension growth, making them a valuable model for studying tumor cell heterogeneity and microenvironment adaptation. KMS-11 is widely used in studies on multiple myeloma, immunoglobulin synthesis, and drug screening.
  • Product Name
    KMS-11
  • Product Type
    Human Myeloma Cell Lines
  • Species
    Human
  • Cell Type
    Lymphocyte-like
  • Source Organ
    Pleural Effusion
  • Product Type
    Human Myeloma Cell Lines
  • Growth Conditions
    37 °C, 5% CO2
  • Application
    KMS-11 can be used to map proliferation-related signaling pathways in myeloma and identify inhibitors for myeloma cell growth and survival.For example, Interleukin-6 (IL-6) was identified as one of the most important growth factors for myeloma cells, inducing enhanced growth in KMS-11 cells, accompanied by down-regulation of protein kinase C (PKC) activity. JAK inhibitor, which can affect the IL-6/JAK signal transduction, induced cell death of the KMS-11 cells and inhibited tumor growth in a KMS-11 xenograft mouse model. For drug development, ginseng was observed as a candidate for the treatment of myeloma. IH901, a derivative of ginseng,triggered several biochemical events, including the cleavage of poly (ADP-ribose) polymerase (PARP), internucleosomal DNA fragmentation, the activation of caspase-3, the down-regulation of FGFR3, the inhibition of ERK activity, and the apoptosis in KMS-11 cell line.
  • Size/Quantity
    1 vial
  • Recommended Medium And Supplement

    RPMI 1640 + 10% FBS
  • Shipping Conditions
    Dry Ice
  • Storage
    Liquid Nitrogen
  • Biosafety Level
    1

Payment & Security

Payment methods

    Your payment information is processed securely. We do not store credit card details nor have access to your credit card information.

    • Visit our support center

      Expert help & advice

    • Check your order status

      Updates & tracking

    • Returns & exchanges

      All you need to know

    • Price-match guarantee

      Our promise to you